---
title: A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans
url: http://arxiv.org/abs/2608.11762v1
type: paper-summary
date: 2026-08-12
source_paper: 2026-08-12_08-01-15Z_AcomparisonofCNNarchitecturesforAlzheimer_sdisease.md
generated_at: 2026-08-12 22:13
model: nvidia/nemotron-3-nano-4b
---

## Summary
This paper evaluates ten convolutional neural network architectures on a held‑out test split of single‑view MRI scans for Alzheimer’s disease detection, achieving the highest validation accuracy with VGG16 at 0.9637 and test accuracy of 0.9533. The study highlights a persistent difficulty in distinguishing between non‑demented and very mild dementia stages across all models.

## Key Takeaways
- The best performing model is VGG16, delivering validation accuracy of 0.9637 and test accuracy of 0.9533 on the balanced subset of OASIS data.  
- All ten architectures exhibit similar performance, indicating that architectural choice alone does not resolve the classification challenge.  
- The transition from non‑demented to very mild dementia remains a consistent difficulty point observed in every model’s results.

## Context
The work contributes to the growing body of AI research that applies deep learning to medical imaging for early disease detection, demonstrating that CNNs can achieve high accuracy on single‑view MRI scans. This study underscores the importance of standardized evaluation protocols and balanced datasets when benchmarking neural network performance in clinical settings.

## Implications
For clinicians and researchers, these findings suggest that while current CNN architectures can detect Alzheimer’s disease with strong metrics, they still struggle to differentiate early stages, limiting their utility for timely intervention. Industry stakeholders should consider integrating multimodal data or alternative detection strategies to address this gap.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.11762v1)
